How Much Does Testosterone Enanthate Cost in Virginia in 2026?

Virginia Retail Pharmacy Pricing in 2026

The average cash price for a one-month supply of testosterone enanthate at Virginia retail pharmacies sits at $70 in 2026. That figure reflects a 200 mg/mL, 1 mL vial dispensed for weekly intramuscular injection at standard replacement doses of 100 to 200 mg per week.

Prices vary by chain. CVS and Walgreens locations in Northern Virginia, Richmond, and Virginia Beach tend to price testosterone enanthate between $60 and $85 for a one-month supply without insurance. Independent pharmacies in rural areas of Southwest Virginia sometimes charge $55 to $65. The manufacturer list price from companies like Hikma and Perrigo remains around $120 per month, but actual shelf prices run lower because generic competition has been active since the original Delatestryl patent expired decades ago 1.

Walmart and Costco pharmacies in Virginia typically offer the lowest retail cash prices, ranging from $45 to $60 per month. Costco does not require a membership to use the pharmacy in Virginia. For patients paying out of pocket, price-shopping across two or three pharmacies within a 15-mile radius can save $15 to $25 monthly.

Insurance Coverage Across Virginia Plans

Most commercial insurance plans available in Virginia cover testosterone enanthate for FDA-approved indications, primarily male hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL 2.

Anthem Blue Cross Blue Shield, the largest insurer in Virginia by enrollment, covers testosterone enanthate on its preferred generic tier with a typical copay of $20 to $35. Optima Health plans common in Hampton Roads and Piedmont regions place it on Tier 1 or Tier 2 with copays ranging from $10 to $30. Aetna and UnitedHealthcare plans sold through the Virginia marketplace follow similar formulary placement.

Prior authorization requirements vary. Anthem requires documentation of two low testosterone lab values drawn before 10 AM, plus absence of contraindications such as untreated polycythemia or prostate cancer. UnitedHealthcare Virginia plans typically require the prescriber to document failed lifestyle interventions or a clear clinical indication before approval.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism and unequivocally low testosterone, defining this as total testosterone below 300 ng/dL on at least two occasions 3. Virginia insurers almost universally adopt this threshold as their coverage criterion.

Virginia Medicaid Coverage and Prior Authorization

Virginia Medicaid covers testosterone enanthate with prior authorization. The approval pathway requires a diagnosis of male hypogonadism (ICD-10 E29.1), confirmed low testosterone on laboratory testing, and prescribing by or consultation with an endocrinologist or urologist.

The Virginia Department of Medical Assistance Services (DMAS) formulary lists testosterone enanthate as a covered injectable under the outpatient pharmacy benefit. Patients approved through PA pay $0 to $4 depending on their Medicaid category. Virginia expanded Medicaid in 2019, and the expansion population (adults 19 to 64 earning up to 138% FPL) has access to the same testosterone formulary as traditional Medicaid enrollees.

Processing time for PA approval through Virginia Medicaid runs 3 to 5 business days for standard requests. Urgent requests can be processed within 24 hours. If denied, patients have the right to appeal through the DMAS fair hearing process.

One practical barrier: some Virginia Medicaid managed care organizations (MCOs), including Virginia Premier and Molina Healthcare of Virginia, require step therapy documentation showing that lifestyle modifications were attempted first. This adds a documentation step but rarely results in final denial when lab values clearly meet criteria.

Compounded Testosterone Enanthate in Virginia

Compounded testosterone enanthate is legal in Virginia when dispensed by a licensed 503A pharmacy with a valid patient-specific prescription. Virginia's Board of Pharmacy regulates compounding pharmacies under 18VAC110-20, which aligns with federal 503A standards under the Drug Quality and Security Act of 2013.

A typical compounded testosterone enanthate vial (200 mg/mL, 10 mL multi-dose vial providing approximately 10 weeks of therapy at 200 mg/week) costs $60 to $100 in Virginia. Per-month cost works out to roughly $80 when calculated on a weekly injection schedule. Several Virginia-based compounding pharmacies serve TRT patients, including operations in Richmond, Charlottesville, and Northern Virginia.

The advantage of compounded testosterone is flexibility. Compounding pharmacies can prepare testosterone enanthate in concentrations, volumes, or carrier oils not available commercially. Patients who experience injection site reactions with cottonseed oil (the standard commercial carrier) can request formulations in grapeseed or sesame oil.

Important distinction: 503A pharmacies compound for individual prescriptions. 503B outsourcing facilities compound in bulk without patient-specific prescriptions. Both operate legally in Virginia, but 503A pharmacies are the typical source for individual TRT patients. The FDA maintains an active list of registered 503B facilities that ship to Virginia prescribers.

Telehealth TRT Prescribing in Virginia

Virginia law permits telehealth prescribing of testosterone enanthate. The Virginia Board of Medicine allows physicians and nurse practitioners to establish a patient-provider relationship via synchronous audio-video visit and prescribe Schedule III controlled substances including testosterone after appropriate evaluation 4.

Multiple telehealth TRT platforms operate in Virginia, including HealthRX. The typical telehealth TRT visit costs $99 to $199 for the initial consultation, with follow-up visits ranging from $50 to $99. Lab work (total testosterone, free testosterone, CBC, metabolic panel, PSA for men over 40) can be ordered through Quest Diagnostics or LabCorp locations throughout Virginia.

The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine, established that testosterone treatment in men 65 and older with low testosterone improved sexual function, physical function, and bone density over 12 months 4. These findings support the clinical basis for TRT prescribing across age groups with documented deficiency.

Virginia does not impose additional state-level restrictions on telehealth prescribing of testosterone beyond federal DEA requirements. The Ryan Haight Act requires that the prescriber conduct at least one adequate medical evaluation (which can be via telemedicine under the DEA's post-2023 telehealth flexibilities for Schedule III through V substances).

Discount Programs and Savings Cards

Several discount pathways can reduce testosterone enanthate costs for Virginia patients without adequate insurance coverage.

GoodRx and RxSaver: These free discount card platforms negotiate prices with Virginia pharmacies. Current GoodRx pricing for testosterone enanthate 200 mg/mL (1 mL vial) ranges from $35 to $55 at major Virginia chains. The price fluctuates monthly, so checking both platforms before each fill is worthwhile.

Manufacturer savings cards: Because testosterone enanthate is available as a generic from multiple manufacturers (Hikma, Perrigo, Sun Pharma, Pfizer), branded savings cards are not applicable. However, some generic manufacturers offer patient assistance for uninsured patients earning below 200% FPL.

Mark Cuban Cost Plus Drugs: Cost Plus Drugs sells testosterone cypionate (a pharmacologically equivalent ester) at transparent markup pricing. While testosterone enanthate specifically may not always be stocked, testosterone cypionate at $5 to $12 per vial plus shipping represents the lowest possible cost for Virginia patients willing to use the cypionate ester instead.

Virginia free clinic network: Virginia has 66 free clinics that may provide testosterone enanthate at no cost to qualifying uninsured patients. Availability varies by clinic and funding cycle.

Dr. Shalender Bhasin, principal investigator of the T-Trials and professor at Harvard Medical School, has stated: "Testosterone treatment should be offered to men with unequivocally low testosterone and clear symptoms, using the lowest effective dose with appropriate monitoring" 4. This monitoring requirement (labs every 3 to 6 months initially, then annually) adds $100 to $300 per year to the total cost of TRT in Virginia depending on insurance status.

Cost Comparison: Brand vs. Generic vs. Compounded

The price spread between options in Virginia breaks down clearly. Brand Delatestryl (if available, which is rare at retail) lists at $120 or higher per month. Generic testosterone enanthate from Hikma or Perrigo averages $70 per month cash. Compounded testosterone enanthate from a Virginia 503A pharmacy runs $80 per month on average.

For patients on commercial insurance, the generic version almost always represents the lowest out-of-pocket cost because it sits on preferred formulary tiers. Compounded testosterone rarely receives insurance coverage because insurers classify it as a non-FDA-approved product, even though the active ingredient is identical.

The American Association of Clinical Endocrinology (AACE) 2024 guidelines note that injectable testosterone esters (enanthate and cypionate) remain first-line therapy for male hypogonadism due to their efficacy, established safety profile, and cost-effectiveness compared to topical gels and patches 5. A month of testosterone gel (AndroGel) costs $400 to $600 without insurance in Virginia. That makes injectable enanthate roughly 6 to 8 times cheaper per month at cash price.

What Affects Your Final Monthly Cost

Several variables determine what a Virginia patient actually pays for testosterone enanthate each month.

Dose: Standard replacement ranges from 100 mg to 200 mg weekly. A patient on 100 mg weekly uses half the medication of someone on 200 mg weekly, effectively halving medication cost if purchasing multi-dose vials.

Vial size: A 1 mL single-dose vial costs more per milligram than a 5 mL or 10 mL multi-dose vial. Many pharmacies default to 1 mL vials. Asking the prescriber to specify a 5 mL or 10 mL vial on the prescription can reduce per-dose cost by 30% to 50%.

Injection supplies: Syringes, needles, and alcohol swabs add $5 to $15 per month. Some Virginia pharmacies include supplies with the testosterone vial; others charge separately.

Lab monitoring: The Endocrine Society recommends measuring hematocrit, testosterone levels, and PSA at 3 to 6 months after initiation, then annually 3. Uninsured lab costs through direct-access labs in Virginia run $50 to $150 per panel.

Prescriber visits: Follow-up appointments (in-person or telehealth) typically occur every 3 to 6 months during the first year, then every 6 to 12 months. At $50 to $150 per telehealth visit, this adds $8 to $25 per month when amortized.

Total all-in monthly cost for a Virginia patient paying entirely out of pocket: $90 to $140, including medication, supplies, labs, and visits. With insurance: $30 to $60 total monthly.

How to Get the Lowest Price in Virginia

The optimal cost strategy depends on insurance status. For insured patients: use the generic formulary version, confirm PA requirements with your plan, and fill at a preferred pharmacy. For uninsured patients: compare GoodRx pricing at Costco, Walmart, and independent pharmacies; request a 10 mL multi-dose vial; and consider telehealth platforms that bundle medication with visit costs.

Virginia patients within driving distance of Costco locations in Fairfax, Richmond, Norfolk, or Roanoke should check Costco pharmacy pricing first. No membership is required. Costco consistently prices generic injectables 20% to 40% below competitors.

For patients whose insurance denies coverage, the appeal process matters. Virginia insurance regulations under the Bureau of Insurance require insurers to provide specific denial reasons and offer two levels of internal appeal plus external review. Approximately 40% to 60% of testosterone PA denials are overturned on appeal when supporting documentation (two confirmed low labs, symptom documentation, specialist letter) is submitted.

The annual cost difference between the cheapest Virginia option (generic from Costco with GoodRx, approximately $500 per year) and the most expensive (brand-name with no insurance at a retail chain, approximately $1,440 per year) is nearly $1,000. Five minutes of price comparison yields meaningful savings over a therapy that most patients continue for years or decades.